Fine particulate matter (PM2.5): The culprit for chronic lung diseases in China

Tao Li; Rong Hu; Zi Chen; Qiyuan Li; Shouxiong Huang; Zhou Zhu; Lin-Fu Zhou

Chronic Diseases and Translational Medicine (Sep 2018)

Fine particulate matter (PM2.5): The culprit for chronic lung diseases in China

Tao Li,
Rong Hu,
Zi Chen,
Qiyuan Li,
Shouxiong Huang,
Zhou Zhu,
Lin-Fu Zhou

Affiliations

Tao Li: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China
Rong Hu: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China
Zi Chen: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China; Section of Allergy and Clinical Immunology, Internal Medicine and Pediatrics, Yale University School of Medicine, New Haven, CT 06511, USA
Qiyuan Li: Department of Translational Medicine, Medical College of Xiamen University, Xiamen, Fujian 361102, China
Shouxiong Huang: Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH 45249, USA
Zhou Zhu: Section of Allergy and Clinical Immunology, Internal Medicine and Pediatrics, Yale University School of Medicine, New Haven, CT 06511, USA
Lin-Fu Zhou: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China; Institute of Integrative Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, China; Department of Respiratory Medicine, Jiangsu Shengze Hospital, Nanjing Medical University, Suzhou, Jiangsu 215228, China; Corresponding author.

Journal volume & issue: Vol. 4, no. 3
pp. 176 – 186

Abstract

Read online

Air pollution is a world public health problem. Particulate matter (PM), a mix of solid and liquid particles in the air, becomes an increasing concern in the social and economic development of China. For decades, epidemiological studies have confirmed the association between fine particle pollutants and respiratory diseases. It has been reported in different populations that increased fine particulate matter (PM2.5) concentrations cause elevated susceptibility to respiratory diseases, including acute respiratory distress, asthma, chronic obstructive pulmonary disease, and lung cancer. This review will discuss the pathophysiology of PM2.5 in respiratory diseases, which are helpful for the prevention of air pollution and treatment of respiratory tract inflammatory diseases. Keywords: Air pollution, Particulate matter, Lung diseases, Chronic obstructive pulmonary disease

Published in Chronic Diseases and Translational Medicine

ISSN: 2095-882X (Print); 2589-0514 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/25890514

About the journal